000 | 01780 a2200517 4500 | ||
---|---|---|---|
005 | 20250513212049.0 | ||
264 | 0 | _c20000815 | |
008 | 200008s 0 0 eng d | ||
022 | _a0934-9723 | ||
024 | 7 |
_a10.1007/s100960050476 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aToledano, H | |
245 | 0 | 0 |
_aProspective surveillance of vancomycin-resistant enterococci in a neonatal intensive care unit. _h[electronic resource] |
260 |
_bEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _cApr 2000 |
||
300 |
_a282-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aCulture Media |
650 | 0 | 4 |
_aEnterococcus _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGram-Positive Bacterial Infections _xepidemiology |
650 | 0 | 4 | _aHospital Units |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 | _aIntensive Care Units, Neonatal |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPopulation Surveillance |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aVancomycin Resistance |
700 | 1 | _aSchlesinger, Y | |
700 | 1 | _aRaveh, D | |
700 | 1 | _aRudensky, B | |
700 | 1 | _aAttias, D | |
700 | 1 | _aEidelman, A I | |
700 | 1 | _aYinnon, A M | |
773 | 0 |
_tEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _gvol. 19 _gno. 4 _gp. 282-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s100960050476 _zAvailable from publisher's website |
999 |
_c10786275 _d10786275 |